Key result
Colforsin daropate exerted potent coronary vasodilator actions and stimulated adenylate cyclase activity significantly more than isoproterenol, dopamine, and dobutamine in canine heart preparations.
Why the study?
Does colforsin daropate improve cardiovascular variables and adenylate cyclase activity compared to catecholamines in canine isolated heart preparations?
Does colforsin daropate improve cardiovascular variables and adenylate cyclase activity compared to catecholamines in canine isolated heart preparations?
Colforsin daropate demonstrates potent coronary vasodilator action and adenylate cyclase stimulation compared to catecholamines, suggesting potential utility in severe heart failure.
Answers are grounded in this paper and cite their sources.
Supports further study of colforsin daropate in heart failure; leaves open clinical translation from canine data.
Colforsin daropate is a recently developed water-soluble derivative of forskolin that directly stimulates adenylate cyclase, unlike the catecholamines. The chronotropic, inotropic and coronary vasodilator actions of colforsin daropate were compared with those of isoproterenol, dopamine and dobutamine, using canine isolated, blood-perfused heart preparations. The stimulating effect of each drug on adenylate cyclase activity was also assessed. Colforsin daropate, as well as each of the catecholamines, exerted positive chronotropic, inotropic and coronary vasodilator actions. The order of selectivity for the cardiovascular variables of colforsin daropate was coronary vasodilation >> positive inotropy > positive chronotropy; whereas that of isoproterenol, dopamine and dobutamine was positive inotropy >> coronary vasodilation > positive chronotropy. Thus, a marked characteristic of colforsin daropate is its potent coronary vasodilator action. On the other hand, each drug significantly increased the adenylate cyclase activity in a dose-related manner: colforsin daropate >> isoproterenol > dopamine = dobutamine. These results suggest that colforsin daropate may be preferable in the treatment of severe heart failure where the coronary blood flow is reduced and beta-adrenoceptor-dependent signal transduction pathway is down-regulated.
No takes yet. Share an insight, caveat, or question.
Yoneyama et al. (2002) studied None (Healthy canine heart preparations) (n=6). Colforsin daropate vs. Isoproterenol, dopamine, and dobutamine was evaluated on Adenylate cyclase activity and cardiovascular parameters (sinoatrial rate, developed tension, coronary blood flow). Colforsin daropate exerted potent coronary vasodilator actions and stimulated adenylate cyclase activity significantly more than isoproterenol, dopamine, and dobutamine in canine heart preparations.
Synapse has enriched 10 related papers. Consider them for comparative context: